Over the past two years, melatonin has evolved from a niche sleep aid into one of the fastest-growing segments within the global wellness and nutraceutical industry.
As consumers became increasingly focused on sleep quality, stress management, and overall well-being, demand for melatonin supplements accelerated across major markets. What was once a seasonal or occasional purchase has now become a regular part of many consumers’ daily health routines.
This shift has created significant opportunities for supplement manufacturers, retailers, and healthcare companies. At the same time, it has introduced new challenges around pricing, supply availability, and production costs.
What Happened to Melatonin Prices in 2025?
Throughout 2025, melatonin prices remained firm across most global markets.
Strong consumer demand, expanding product portfolios, and growing awareness of sleep health supported higher pricing levels. By mid-2025, melatonin prices in North America had reached approximately USD 92,500 per metric ton, reflecting the industry’s strong growth momentum.
Several countries reported elevated pricing levels during the first quarter of the year.
| Region | Average Price (Q1 2025) |
|---|---|
| Spain | USD 87,936/MT |
| United States | USD 86,551/MT |
| France | USD 79,626/MT |
| Canada | USD 76,164/MT |
| China | USD 73,378/MT |
Demand was particularly strong for gummies, chewable tablets, fast-dissolve products, and combination sleep-support supplements that included melatonin alongside vitamins and herbal ingredients.
Major supplement companies such as Natrol, Spring Valley, CVS Health, Nature Made, and several private-label brands continued expanding their sleep-health portfolios to meet growing consumer demand.
Why Were Prices Increasing?
Several market forces worked together to push melatonin prices higher.
The biggest factor was sustained consumer demand. Sleep disorders, irregular work schedules, and increasing awareness of mental wellness encouraged more consumers to seek non-prescription sleep solutions.
Another important factor was the rising cost of raw materials. Melatonin production relies on specialized chemical inputs, and fluctuations in the availability of these ingredients increased manufacturing expenses for many producers.
Supply chain challenges also played a role. Transportation costs, shipping delays, and international trade disruptions created additional pressure on suppliers, making it more expensive to move products through the global market.
Because melatonin manufacturing capacity is concentrated among a relatively small number of producers, even minor disruptions had a noticeable impact on pricing.
A Temporary Slowdown in Late 2025
While the overall trend remained positive, prices did not increase continuously throughout the year.
During the final quarter of 2025, some regions experienced temporary pricing corrections. Higher inventory levels and cautious purchasing behavior from supplement manufacturers reduced immediate buying activity.
Many companies chose to utilize existing inventory rather than place large new orders. This helped stabilize the market and created a brief period of softer pricing.
However, the slowdown was largely viewed as temporary rather than a sign of weakening demand.
Prices Began Rising Again in 2026
By early 2026, upward pricing pressure had returned.
Higher raw-material costs, tighter supply conditions, and ongoing logistics challenges pushed melatonin prices higher once again. Consumer demand remained healthy across both retail and e-commerce channels, particularly for gummy formulations and premium sleep-support products.
The long-term outlook continued to be supported by growing consumer interest in sleep health.
A significant portion of adults report experiencing sleep-related issues, while younger consumers—including Millennials and Gen Z—have become major purchasers of melatonin supplements. These demographic trends continue to support market expansion.
What Healthcare Leaders Should Watch Next
Looking ahead, melatonin remains one of the most promising categories within the global supplement industry.
Industrial-grade melatonin prices entering 2026 generally ranged between USD 63 and USD 91 per kilogram, depending on purity, supplier agreements, and regional market conditions. Analysts expect prices to remain relatively firm as demand continues to outpace supply growth.
For healthcare companies, supplement manufacturers, and retailers, the focus will increasingly shift toward securing reliable supply chains, maintaining product quality, and managing procurement costs.
The melatonin story is no longer simply about helping people sleep better. It reflects a broader transformation in consumer healthcare, where preventive wellness, mental health awareness, and lifestyle management are driving entirely new patterns of demand.
As the market moves through 2026, one thing is becoming increasingly clear: consumer interest in sleep health is not slowing down. The companies that can balance supply reliability with rising demand will be best positioned to succeed in the next phase of growth.
Get Easy Access
Access our exclusive, data-rich dashboard dedicated to the Pharmaceutical Industry – built specifically for decision-makers, strategists, and industry leaders. The dashboard features comprehensive statistical data, segment-wise market breakdowns, regional performance shares, detailed company profiles, annual updates, and much more. From market sizing to competitive intelligence, this powerful tool is one-stop solution to your gateway.
Access the Dashboard: https://www.towardshealthcare.com/access-dashboard
About Us
Healthcare WebWire is sister firm of Towards Healthcare Research and Consulting provides strategic intelligence and research expertise across the pharmaceutical market, including branded drugs, generic medicines, biologics, biosimilars, specialty pharmaceuticals, OTC products, and drug delivery systems. We support pharmaceutical companies with market analysis, pipeline assessment, and competitive insights to help drive innovation, strengthen commercialization strategies, and capture emerging growth opportunities in the evolving healthcare landscape.
You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com
Europe Region – +44 778 256 0738
North America Region – +1 8044 4193 44
APAC Region: +91 9356 9282 04
Visit Our Website: https://www.towardshealthcare.com
Find us on social platforms: LinkedIn | Twitter | Instagram | Medium